Entrada Therapeutics, Inc. Quarterly Depreciation in USD from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Entrada Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q3 2020 to Q2 2024.
  • Entrada Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $900K, a 28.6% increase year-over-year.
  • Entrada Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $3.43M, a 52.9% increase year-over-year.
  • Entrada Therapeutics, Inc. annual Depreciation for 2023 was $2.84M, a 49.9% increase from 2022.
  • Entrada Therapeutics, Inc. annual Depreciation for 2022 was $1.9M, a 69.7% increase from 2021.
  • Entrada Therapeutics, Inc. annual Depreciation for 2021 was $1.12M, a 243% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $3.43M $900K +$200K +28.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $3.23M $934K +$393K +72.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $2.84M $800K +$295K +58.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $2.55M $800K +$300K +60% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $2.25M $700K +$200K +40% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $2.05M $541K +$151K +38.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $1.9M $505K +$187K +58.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $1.71M $500K +$200K +66.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $1.51M $500K +$200K +66.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $1.31M $390K +$191K +96% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $1.12M $318K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 $300K +$200K +200% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $300K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $199K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $100K Jul 1, 2020 Sep 30, 2020 10-Q 2021-12-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.